PATENT CLAIM ANALYSIS

Application Number: 16124497
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "255030"]

Abstract:
The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.

Claim (Index 15):
The method according to  claim 14  wherein said further disease said patient is selected from type II diabetes, hypertension or coronary heart diseases, or said patient is abstaining from nicotine.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12741780', '15043167', '15315182', '14767350', '14649087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7536478073283052
- 35 USC 102 Novelty (BERT): 0.5183569710591979
- Combined Prediction Score: 0.7301187237013944
- Mean Citation Score: 211.074214
- Max Citation Score: 229.31255
- Similarity Product: 121.34699791855216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test